Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein Blockage Causes Motor Neuron Disease

By Biotechdaily staff writers
Posted on 11 Jun 2002
Using a transgenic mouse model, researchers have shown that an accumulation of dynamitin can cause motor neuron degeneration such as that observed in amyotrophic lateral sclerosis (ALS). More...
Their study, published in the May 30, 2002, issue of Neuron, was designed to test the hypothesis that disruption of neuronal transport could account for the development of motor neuron disease.

A line of mice was engineered that overexpressed dynamitin, an element of the complex that binds and transports protein along the axons. The investigators, from the University of Pennsylvania (Philadelphia, USA), found that mice overexpressing dynamitin displayed a late-onset progressive motor neuron degenerative disease characterized by decreased strength and endurance, motor neuron degeneration and loss, and denervation of muscle.

Dynamitin overexpression was found to disassemble dynactin, a required activator of cytoplasmic dynein, resulting in an inhibition of retrograde axonal transport. "Our mouse model shows that disruption of this neuronal transport is sufficient to cause motor neuron degeneration,” explained Dr. Erika Holzbaur, who led the research team. "We hypothesize that, in humans, different insults (either inheritable or environmental) may lead to disruptions in this continuous transport process. Once it is disrupted, the health of the neuron will decline over time, resulting in the motor neuron degeneration seen in ALS.”

The investigators suggest that in light of these findings, future therapies for motor neuron diseases should seek to restore the normal flow of protein in motor neurons.



Related Links:
University of Pennsylvania

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.